Timothy Patton

Dr. Timothy Patton

University of Melbourne, Melbourne, Victoria, Australia
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Immunity
Verified
Journal Article
Closed access
LTLuyi Tian
Luyi Tian
STSara Tomei
Sara Tomei
JSJaring Schreuder
Jaring Schreuder
TWTom S. Weber
Tom S. Weber
DZDaniela Bettina Zalcenstein
Daniela Bettina Zalcenstein
SNShalin H. Naik
Shalin H. Naik

17 January 2025 in Journal of Experimental Medicine
Verified
Journal Article
Open access
WAWael Awad
Wael Awad
JMJemma R. Mayall
Jemma R. Mayall
WXWeijun Xu
Weijun Xu
Matt JohansenMatt Johansen
Matt Johansen
TPTimothy Patton
Timothy Patton
JRJamie Rossjohn
Jamie Rossjohn
Tobacco smoking is prevalent across the world and causes numerous diseases. Cigarette smoke (CS) compromises immunity, yet little is known of the components of CS that impact T cell function. MR1 is a ubiquitous molecule that presents bacterial metabolites to MAIT cells, which are highly abundant in the lungs. Using in silico, cellular, and biochemical approaches, we identified components of CS that bind MR1 and impact MR1 cell surface expression. Compounds, including nicotinaldehyde, phenylpropanoid, and benzaldehyde-related scaffolds, bound within the A′ pocket of MR1. CS inhibited MAIT cell activation, ex vivo, via TCR-dependent and TCR-independent mechanisms. Chronic CS exposure altered MAIT cell phenotype and function and attenuated MAIT cell responses to influenza A virus infection in vivo. MR1-deficient mice were partially protected from the development of chronic obstructive pulmonary disease (COPD) features that were associated with CS exposure. Thus, CS can impair MAIT cell function by diverse mechanisms, and potentially contribute to infection susceptibility and disease exacerbations.

18 March 2022 in International Journal of Eating Disorders
Verified
Journal Article
Open access
LMLaura Karina Milton
Laura Karina Milton
TPTimothy Patton
Timothy Patton
MOMeredith O'Keeffe
Meredith O'Keeffe
BOBrian John Oldfield
Brian John Oldfield
CFClaire Jennifer Foldi
Claire Jennifer Foldi
Objective: Identifying risk factors that contribute to the development of anorexia nervosa (AN) is critical for the implementation of early intervention strategies. Anxiety, obsessive–compulsive behavior, and immune dysfunction may be involved in the development of AN; however, their direct influence on susceptibility to the condition remains unclear. Here, we used the activity‐based anorexia (ABA) model to examine whether activity, anxiety‐like behavior, compulsive behavior, and circulating immune markers predict the subsequent development of pathological weight loss.Method: Female Sprague–Dawley rats (n = 44) underwent behavioral testing before exposure to ABA conditions after which they were separated into susceptible and resistant subpopulations. Blood was sampled before behavioral testing and after recovery from ABA to screen for proinflammatory cytokines.Results: Rats that were vulnerable to pathological weight loss differed significantly from resistant rats on all key ABA parameters. While the primary measures of anxiety‐like or compulsive behavior were not shown to predict vulnerability to ABA, increased locomotion and anxiety‐like behavior were both associated with the extent of weight loss in susceptible but not resistant animals. Moreover, the change in expression of proinflammatory markers IL‐4 and IL‐6 evoked by ABA was associated with discrete vulnerability factors. Intriguingly, behavior related to risk assessment was shown to predict vulnerability to ABA.Discussion: We did not find undisputable behavioral or immune predictors of susceptibility to pathological weight loss in the ABA rat model. Future research should examine the role of cognition in the development of ABA, dysfunction of which may represent an endophenotype linking anorectic, anxiety‐like and compulsive behavior.Public Significance: Anorexia nervosa (AN) has among the highest mortality rates of all psychiatric disorders and treatment options remain limited in their efficacy. Understanding what types of risk factors contribute to the development of AN is essential for implementing early intervention strategies. This study describes how some of the most common psychological features of AN could be used to predict susceptibility to pathological weight loss in a well‐established animal model.

11 February 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
TPTimothy Patton
Timothy Patton
ZZZhe Zhao
Zhe Zhao
XLXin Yi Lim
Xin Yi Lim
EEEleanor Eddy
Eleanor Eddy
HWHuimeng Wang
Huimeng Wang
ACAlexandra Corbett
Alexandra Corbett
Cell death mechanisms in T lymphocytes vary according to their developmental stage, cell subset and activation status. The cell death control mechanisms of mucosal-associated invariant T (MAIT) cells, a specialized T cell population, are largely unknown. Here we report that MAIT cells express key necroptotic machinery; receptor-interacting protein kinase 3 (RIPK3) and mixed lineage kinase domain-like (MLKL) protein, in abundance. Despite this, we discovered that the loss of RIPK3, but not necroptotic effector MLKL or apoptotic caspase-8, specifically increased MAIT cell abundance at steady-state in the thymus, spleen, liver and lungs, in a cell-intrinsic manner. In contrast, over the course of infection with Francisella tularensis, RIPK3 deficiency did not impact the magnitude of the expansion nor contraction of MAIT cell pools. These findings suggest that, distinct from conventional T cells, the accumulation of MAIT cells is restrained by RIPK3 signalling, likely prior to thymic egress, in a manner independent of canonical apoptotic and necroptotic cell death pathways.

19 April 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
NJNazneen Jahan
Nazneen Jahan
TPTimothy Patton
Timothy Patton
MOMeredith O'Keeffe
Meredith O'Keeffe
Staphylococcus aureus (S. aureus) causes a broad range of infections and is associated with significant morbidity and mortality. S. aureus produces a diverse range of cellular and extracellular factors responsible for its invasiveness and ability to resist immune attack. In recent years, increasing resistance to last-line anti-staphylococcal antibiotics daptomycin and vancomycin has been observed. Resistant strains of S. aureus are highly efficient in invading a variety of professional and nonprofessional phagocytes and are able to survive inside host cells. Eliciting immune protection against antibiotic-resistant S. aureus infection is a global challenge, requiring both innate and adaptive immune effector mechanisms. Dendritic cells (DC), which sit at the interface between innate and adaptive immune responses, are central to the induction of immune protection against S. aureus. However, it has been observed that S. aureus has the capacity to develop further antibiotic resistance and acquire increased resistance to immunological recognition by the innate immune system. In this article, we review the strategies utilised by S. aureus to circumvent antibiotic and innate immune responses, especially the interaction between S. aureus and DC, focusing on how this relationship is perturbed with the development of antibiotic resistance.

26 September 2019 in Immunology & Cell Biology
Verified
Journal Article
Closed access
PDF file
TPTimothy Patton
Timothy Patton
JJJhih-Hang Jiang
Jhih-Hang Jiang
RLRachel J Lundie
Rachel J Lundie
MBMariam Bafit
Mariam Bafit
WGWei Gao
Wei Gao
MOMeredith O'Keeffe
Meredith O'Keeffe